People with opioid use disorder (OUD) frequently require prolonged hospital and skilled nursing facility care for complications of their drug use—including wounds, endocarditis, hepatitis, HIV/AIDS, and acute exacerbations of chronic diseases. In 2012, there were 500 000 hospitalizations related to OUD in the United States; in about 1 in 10 of these admissions, the patient was discharged to a skilled nursing facility.1 Current federal regulations, however, complicate the provision of effective treatment for OUD in hospitals and skilled nursing facilities. As a result, many patients experience costly cycles of complications, admission, discharge, repeated complications, and readmission with little gain to their health. In this Viewpoint, we argue that changing regulations of the Substance Abuse and Mental Health Services Administration (SAMHSA) and the Drug Enforcement Administration (DEA) to align with evidence could expand access to care and save lives.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Pytell JD, Sharfstein JM, Olsen Y. Facilitating Methadone Use in Hospitals and Skilled Nursing Facilities. JAMA Intern Med. 2020;180(1):7–8. doi:10.1001/jamainternmed.2019.5731
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: